BNP Paribas announces that it has now received all necessary approvals and completed the acquisition of 100% of Exane, thus raising its stake from the 50% previously held during a successful 17-year partnership. This milestone represents a new chapter for

The Board of Directors of BNP Paribas met on 29 April 2021. The meeting was chaired by Jean Lemierre, and the Board examined the Group’s results for the first quarter 2021.

After a successful 17-year partnership, BNP Paribas is looking to acquire up to 100% of Exane*, raising its stake from the 50% currently held.

    The Board of Directors of BNP Paribas met on 4 February 2021, chaired by Jean Lemierre. The Board examined the Group’s results for the fourth quarter and endorsed the 2020 financial statements.

The Board of Directors of BNP Paribas met on 2 November 2020. The meeting was chaired by Jean Lemierre and the Board examined the Group’s results for the third quarter 2020.

Board of Directors of BNP Paribas met on 30 July 2020. The meeting was chaired by Jean Lemierre and the Board examined the Group’s results for the second quarter 2020 and endorsed the interim financial statements for the first half…

The Board of Directors of BNP Paribas met on 4 May 2020. The meeting was chaired by Jean Lemierre, and the Board examined the Group’s results for the first quarter 2020.

In an unprecedented context and taking into consideration the recommendations issued by the European Central Bank on 27 March 2020 with respect to dividend distributions during the COVID-19 pandemic, BNP Paribas’ Board of Directors met on 2 April 2020, with

 The Board of Directors of BNP Paribas met on 4 February 2020. The meeting was chaired by Jean Lemierre and the Board examined the Group’s results for the fourth quarter and endorsed the 2019 financial statements.        Read…